Beauty Health (NASDAQ:SKIN – Get Rating) had its price objective decreased by stock analysts at Canaccord Genuity Group from $27.00 to $22.00 in a research note issued to investors on Wednesday, The Fly reports. Canaccord Genuity Group’s target price suggests a potential upside of 76.00% from the company’s previous close.
A number of other analysts also recently commented on the stock. Benchmark boosted their price objective on shares of Beauty Health from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, March 14th. JPMorgan Chase & Co. began coverage on shares of Beauty Health in a report on Friday, March 11th. They set an “overweight” rating and a $24.00 price objective on the stock. Zacks Investment Research raised shares of Beauty Health from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a report on Saturday, February 26th. DA Davidson decreased their price objective on shares of Beauty Health from $35.00 to $24.00 in a report on Wednesday. Finally, Piper Sandler decreased their price objective on shares of Beauty Health from $26.00 to $24.00 in a report on Wednesday. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $25.55.
NASDAQ SKIN opened at $12.50 on Wednesday. The company has a debt-to-equity ratio of 2.41, a quick ratio of 12.63 and a current ratio of 13.09. Beauty Health has a one year low of $10.73 and a one year high of $30.17. The firm’s fifty day moving average is $15.85 and its two-hundred day moving average is $19.27.
Beauty Health (NASDAQ:SKIN – Get Rating) last issued its earnings results on Tuesday, February 22nd. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.04. The firm had revenue of $77.90 million during the quarter, compared to analysts’ expectations of $70.90 million. The firm’s revenue for the quarter was up 106.1% compared to the same quarter last year. As a group, research analysts expect that Beauty Health will post 0.09 earnings per share for the current year.
Several large investors have recently bought and sold shares of SKIN. The Manufacturers Life Insurance Company increased its position in Beauty Health by 68.7% during the third quarter. The Manufacturers Life Insurance Company now owns 43,217 shares of the company’s stock worth $1,122,000 after purchasing an additional 17,594 shares during the last quarter. Bluestein R H & Co. acquired a new position in Beauty Health during the third quarter worth approximately $390,000. Wellington Management Group LLP acquired a new position in Beauty Health during the third quarter worth approximately $35,426,000. Goldman Sachs Group Inc. increased its position in Beauty Health by 633.5% during the third quarter. Goldman Sachs Group Inc. now owns 421,745 shares of the company’s stock worth $10,952,000 after purchasing an additional 364,248 shares during the last quarter. Finally, Lord Abbett & CO. LLC acquired a new position in Beauty Health during the third quarter worth approximately $56,687,000. 72.01% of the stock is owned by institutional investors and hedge funds.
About Beauty Health (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
Receive News & Ratings for Beauty Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Beauty Health and related companies with MarketBeat.com’s FREE daily email newsletter.